Trials / Completed
CompletedNCT00753051
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)
Treatment of Clozapine-resistant Schizophrenia : Comparison Between Augmentation With Haloperidol and Electroconvulsive Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Khon Kaen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clozapine treatment resistant schizophrenia is still prevalent.The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determined.This study is a randomized control trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clozapine+haloperidol | clozapine 300-900 mg/d haloperidol 4-60 mg/d |
| DRUG | clozapine,electroconvulsive therapy | clozapine 300-900 mg/d electroconvulsive therapy 4-12 times |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2012-03-01
- Completion
- 2012-05-01
- First posted
- 2008-09-16
- Last updated
- 2012-05-07
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00753051. Inclusion in this directory is not an endorsement.